# A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

> **NCT00780975** · PHASE2 · TERMINATED · sponsor: **PharmaMar** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Aplidin (plitidepsin)

## Key facts

- **NCT ID:** NCT00780975
- **Lead sponsor:** PharmaMar
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00780975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00780975, "A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00780975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*